ArticleOncoimmunology2016

Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies.

Alistair M Cook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.